Placenta Growth Factor

• 

  Subject Areas on Research

  • Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. 
  • Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma. 
  • Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. 
  • Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester. 
  • Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. 
  • Early-pregnancy prediction of risk for pre-eclampsia using maternal blood leptin/ceramide ratio: discovery and confirmation. 
  • Exposure to perfluorobutane sulfonate and perfluorooctanesulfonic acid disrupts the production of angiogenesis factors and stress responses in human placental syncytiotrophoblast. 
  • First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. 
  • Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia. 
  • Placenta growth factor in sickle cell disease: association with hemolysis and inflammation. 
  • Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. 
  • The effect of cigarette smoke extract on trophoblast cell viability and migration: the role of adrenomedullin.